Absci Corporation (ABSI) vs Astrana Health, Inc. (ASTH)

A side-by-side comparison of Absci Corporation and Astrana Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ABSI vs ASTH

growth of $100 · dividends reinvested · last 5y
ABSI -46.6% (-11.8%/yr)ASTH -52.7% (-13.9%/yr)ABSI compounded faster over this window
050100150Start $10020222023202420252026$53$47
ABSI ASTH

ABSI vs ASTH: by the numbers

  • •ASTH is the larger company ($1.84B vs $1.78B market cap).
  • •ASTH is profitable (1.05% net margin) while ABSI runs a net loss (-7756.37%).
  • •ASTH grew revenue faster over the past five years (53.77% vs -22.08% CAGR).

Metrics side by side

Valuation

MetricABSIASTH
P/E ratioN/A45.37
Forward P/EN/A26.53
P/S ratio1140.440.48
P/B ratio7.232.22
EV / EBITDAN/A13.51
FCF yieldN/A8.61%

Profitability

MetricABSIASTH
Gross margin-319.36%9.22%
Operating margin-4454.21%2.61%
Net margin-7756.37%1.05%
ROE-49.19%4.88%
ROIC-52.66%4.13%

Growth (annualized)

MetricABSIASTH
Revenue CAGR (5Y)-22.08%53.77%
EPS CAGR (5Y)N/A-15.06%
FCF CAGR (5Y)N/A18.35%
Total return CAGR (5Y)0.89%-16.52%

Frequently asked

Which has grown faster, ABSI or ASTH?
Over the past five years, ASTH grew revenue faster — ABSI at a -22.08% CAGR versus ASTH at 53.77%.
Is ABSI or ASTH more profitable?
ASTH runs the higher net margin — ABSI at -7756.37% versus ASTH at 1.05%.
How have ABSI and ASTH total returns compared?
Over the past 5 years, ABSI delivered 0.89% and ASTH delivered -16.52% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.